Association between nucleoside analogues and risk of hepatitis B virus–related hepatocellular carcinoma recurrence following liver resection.

By Chun-Ying Wu, Yi-Ju Chen, H. Ho, Yao-Chun Hsu, Ken-Nan Kuo, Ming-Shiang Wu, Jaw-Town Lin. Journal of the American Medical Association (JAMA), 2012

799 citations recorded by the source corpus.

Subfields: Epidemiology, Hepatology, Oncology

View Paper: https://www.semanticscholar.org/paper/2a0435c8cdb24c5d2f99df8e25fc0be1493e76bd

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. M. Kudo

In Hepatology

1. M. Kudo
2. A. Cheng

Citations in the corpus

• Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update (2015, neutral): “001) [517].”
• Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update (2017, background): “In addition, a large-scale nationwide cohort study was reported from the Taiwan National Health Insurance Research Database [188].”